Skip to main content
European Commission logo print header

Gene therapy for retinal degeneration

Objectif

Retinal degenerations are a major cause of blindness in the European Union. The aim of this proposal is to develop somatic gene therapy for these conditions. The central issue which must be addressed is the safe and efficient delivery of therapeutic genes to photoreceptor cells. In this proposal we aim to improve our delivery system and assess its efficacy in an animal model.

Appel à propositions

Data not available

Coordinateur

UNIVERSITY COLLEGE LONDON
Contribution de l’UE
Aucune donnée
Adresse
Bath Street 11-43
EC1V 9EL LONDON
Royaume-Uni

Voir sur la carte

Coût total
Aucune donnée